Building on these results, our bioinformatic analysis identifies a potential mechanistic basis for morusin's antitumor and anti-NPC effects, suggesting the induced downregulation of STAT3, AKT1, MMP, and NF-κB 27, 33, 34. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.